EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS, formerly known as Eczacibasi Ilac Sanayi ve Ticaret A.S., (EIS) is a Turkey-based company active in the pharmaceutical industry through its subsidiaries, affiliates and joint ventures. Its product portfolio consists of drugs for human health, veterinary drugs and personal care products, such as body and facial creams, hair gels, deodorants and various other products. The Company is also engaged in real estate development and construction through its subsidiary, Eczacibasi Gayrimenkul Gelistirme ve Yatirim A.S., formerly known as Eczacibasi Insaat ve Ticaret A.S. Its subsidiaries also include Eczacibasi Ilac Ticaret A.S. (EIT), EHP Eczacibasi Health Care Products Joint Stock Co. (EHP), and Eczacibasi Gayrimenkul Gelistirme ve Yatirim A.S., among others. EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a member of Eczacibasi Group of Companies.

Employees

891

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-11-10	TRY 49.70	-3.50%	3,066,258
26-11-09	TRY 51.50	+4.38%	2,267,292
26-11-06	TRY 49.34	+1.94%	3,633,417
26-11-05	TRY 48.40	+0.67%	3,186,149
26-11-04	TRY 48.08	+5.39%	3,051,004

Delayed Quote Borsa Istanbul

More quotes

Market Closed - Borsa Istanbul 10:09:20 2026-11-10 EST			5-day change	1st Jan Change
49.70 ^TRY	-3.50%		+8.94%	-39.24%

10-27	EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
08-06	EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Market Cap	34.06B 678M 608M 560M 509M 963M 63.57B 990M 6.71B 2.67B 2.54B 2.49B 108B	P/E 2024	31.9x	P/E 2025	26.8x
Enterprise Value	32.37B 644M 578M 533M 484M 915M 60.42B 941M 6.38B 2.54B 2.42B 2.37B 102B	EV / Sales 2024	3.78x	EV / Sales 2025	5.51x
Free-Float	22.05%	Yield 2024	3.68%	Yield 2025	1.82%

10-27	EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
08-06	EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-08	Eis Eczacibasi Q1 net result turns to loss of 924 million lira yoy	RE
05-08	EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-04	Eis Eczacibasi says it decides to pay cash dividend at gross 1.75 lira per share for 2025	RE
04-14	EIS Eczacibasi Ilac says Eczacibasi Holding sells 2.1 bln lira worth of shares in company	RE
03-30	Eis Eczacibasi says it proposes to pay cash dividend at gross 1.75 lira per share for 2025	RE
03-26	EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. announces Annual dividend, payable on May 08, 2026	CI
03-23	Eis Eczacibasi Ilac says Eczacibasi Holding signs agreement to sell all Sanipak shares to Arch Peninsula on March 20	RE
03-09	EIS Eczacibasi Ilac signs letter of intent with BV Portfoy for establishment of a venture capital investment fund	RE
03-03	Eis Eczacibasi FY net profit up at 2.09 bln lira YoY	RE
03-02	EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-04	EIS Eczacibasi Ilac says unit Gensenta to cease all production at Sekerpinar facility	RE

1 day	-3.50%
1 week	+8.94%
Current month	+16.39%
1 month	-20.22%
3 months	-29.50%
6 months	-45.41%
Current year	-39.24%

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret Stock

Stocks

ECILC

TRAECILC91E0

Pharmaceuticals

Valuation: EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret

Chart: EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret

Latest news: EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret

Press Releases: EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret

News in other languages: EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret

Quotes and Performance

Price Extremes

Managers and Directors: EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

1 week	47.08	52.45
1 month	40.7	62.3
Current year	40.7	132.6
1 year	40.7	132.6
3 years	37.2	132.6
5 years	6.13	132.6
10 years	2.14	132.6

Manager	Title	Age	Since
Emin Fadillioglu CEO	Chief Executive Officer	-	2022-08-31
Tugce Fatwa IRC	Investor Relations Contact	-	2024-06-30
Esra Eczacibasi Coskun PRN	Corporate Officer/Principal	-	-

Director	Title	Age	Since
Ferit Bülent Eczacibasi CHM	Chairman	-	1981-04-02
Rahmi Faruk Eczacibasi BRD	Director/Board Member	72	1993-03-30
Atalay Muharrem Gümrah BRD	Director/Board Member	59	2018-04-11

Date	Insider	Type	Main position	Quantity	% Market Cap.
3/28/22	ECZACIBASI YATIRIM HOLDING ORTAKLIGI AS	Buy	Company	101,290	0.0148%
3/21/22	ECZACIBASI YATIRIM HOLDING ORTAKLIGI AS	Buy	Company	126,840	0.0185%
3/18/22	ECZACIBASI YATIRIM HOLDING ORTAKLIGI AS	Buy	Company	467,287	0.0682%

	2024	2025
Net sales	8.77B 175M 157M 144M 131M 248M 16.36B 255M 1.73B 688M 655M 641M 27.72B	9.87B 197M 176M 162M 147M 279M 18.42B 287M 1.94B 775M 737M 722M 31.2B
Net income	1.02B 20.38M 18.27M 16.84M 15.29M 28.95M 1.91B 29.75M 202M 80.34M 76.47M 74.85M 3.24B	2.09B 41.58M 37.29M 34.37M 31.21M 59.07M 3.9B 60.72M 411M 164M 156M 153M 6.6B
Net Debt	513M 10.21M 9.16M 8.44M 7.66M 14.5M 957M 14.91M 101M 40.26M 38.32M 37.5M 1.62B	-1.69B -33.57M -30.11M -27.74M -25.2M -47.69M -3.15B -49.02M -332M -132M -126M -123M -5.33B

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET	-3.50%	+8.94%	-39.39%	+9.81%	703M
ELI LILLY AND COMPANY	+1.44%	+1.63%	+48.17%	+139.63%	1,258B
JOHNSON & JOHNSON	-0.47%	+5.49%	+49.03%	+90.68%	679B
ABBVIE INC.	+0.20%	+2.76%	+34.37%	+112.06%	518B
ROCHE HOLDING AG	+0.17%	+2.76%	+44.07%	+69.71%	390B
MERCK & CO., INC.	-0.48%	+2.34%	+70.66%	+46.02%	367B
NOVARTIS AG	+0.76%	+2.27%	+31.59%	+60.36%	307B
ASTRAZENECA PLC	-1.29%	+0.90%	+5.77%	+37.60%	293B
AMGEN INC.	0.00%	+0.86%	+43.74%	+74.04%	252B
GILEAD SCIENCES, INC.	+0.92%	+2.03%	+44.62%	+125.07%	210B
Average	-0.38%	+2.45%	+33.26%	+76.50%	427B
Weighted average by Cap.	-0.09%	+1.18%	+43.65%	+96.82%